96LBA Late Breaking - Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924.

Authors :: Andric, Z.
Ceric, T.
Stanetic, M.
Rancic, M.
Jakopovic, M.
Aix, S. Ponce
Ramlau, R.
Smit, E.
Ulanska, M.
Caldwell, C.
Ferrari, D.
Annis, A.
Vukovic, V.
Zaric, B.
Source :: European Journal of Cancer. 2020 Supplement 2, Vol. 138, pS5-S5. 1p.
Publication Year :: 2020

Subjects :: *ANTINEOPLASTIC agents
*BONE marrow
*CONFERENCES & conventions
*DRUG toxicity
*PROTEINS
*SMALL cell carcinoma
*CHEMICAL inhibitors

Full Text Access

Tools